Hypopyon and Vision Loss after Initially Complication-Free Cataract Surgery

References
1 Seal DV, Barry P, Gettinby G. et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. J Cataract Refract Surg 2006; 32: 396-406
2 Sridhar J, Kuriyan AE, Flynn jr. HW. et al. Endophthalmitis Caused by Serratia marcescens: Clinical features, Antibiotic Susceptibilities, and Treatment Outcomes. Retina 2015; 35: 1095-1100
3 Shah S, Bansal A, Rabinowitz M. et al. Endogenous Serratia marcescens endophthalmitis. Retin Cases Brief Rep 2014; 8: 7-9
4 Park CY, Lee JK, Chuck RS. Toxic anterior segment syndrome-an updated review. BMC Ophthalmol 2018; 18: 276
5 Yazgan S, Celik U, Ayar O. et al. The role of patientʼs systemic characteristics and plateletcrit in developing toxic anterior segment syndrome after uneventful phaco surgery: A case control study. Int Ophthalmol 2018; 38: 43-52
6 Lockington D, Macdonald ECA, Young D. et al. Presence of free radicals in intracameral agents commonly used during cataract surgery. Br J Ophthalmol 2010; 94: 1674-1677
7 Théa Pharmaceuticals. Aprokam® by is the commercial name of an ophthalmic cefuroxime solution that is prophylactically used in phacoemulsification surgery. Accessed December 5, 2023 at: https://www.theapharma.ch/de/produkte/aprokam
8 Gardner S, Barry P, Cordovés L. Toxic anterior segment syndrome and intracameral injection of cefuroxime axetil. Clin Ophthalmol 2015; 9: 1865-1867
9 Çakir B, Celik E, Aksoy NÖ. et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracameral use of cefuroxime. Clin Ophthalmol 2015; 9: 493-497
10 Sengillo JD, Chen Y, Garcia DP. et al. Postoperative endophthalmitis and toxic anterior segment syndrome prophylaxis. Ann Transl Med 2020; 8: 1548